Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumitake Amemiya

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Hepatology Communications|September 24, 2021
Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment EfficacyMasaru Muraoka, Shinya Maekawa, Ryo Katoh, et al.
Plos One|February 23, 2019
HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markersYuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 22, 2020
Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapyShuya Matsuda, Shinya Maekawa, Yasuyuki Komiyama, et al.
Hepatology Communications|March 31, 2022
Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencingKozue Yamauchi, Mitsuaki Sato, Leona Osawa, et al.
Journal of Gastroenterology|November 3, 2017
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis CShinya Maekawa, Mitsuaki Sato, Natsuhiko Kuratomi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 24, 2018
Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinomaYuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 18, 2014
Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imagingNobutoshi Komatsu, Utaroh Motosugi, Shinya Maekawa, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 14, 2022
Spontaneous portosystemic shunt diameter predicts liver function after balloon-occluded retrograde transvenous obliterationAkihisa Tatsumi, Shinya Maekawa, Leona Osawa, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Hepatology Communications|September 24, 2021
Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment EfficacyMasaru Muraoka, Shinya Maekawa, Ryo Katoh, et al.
Plos One|February 23, 2019
HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markersYuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 22, 2020
Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapyShuya Matsuda, Shinya Maekawa, Yasuyuki Komiyama, et al.
Hepatology Communications|March 31, 2022
Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencingKozue Yamauchi, Mitsuaki Sato, Leona Osawa, et al.
Journal of Gastroenterology|November 3, 2017
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis CShinya Maekawa, Mitsuaki Sato, Natsuhiko Kuratomi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 24, 2018
Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinomaYuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 18, 2014
Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imagingNobutoshi Komatsu, Utaroh Motosugi, Shinya Maekawa, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 14, 2022
Spontaneous portosystemic shunt diameter predicts liver function after balloon-occluded retrograde transvenous obliterationAkihisa Tatsumi, Shinya Maekawa, Leona Osawa, et al.
Pageof 4